Knowledge and Network Typology
This chapter develops a matrix that plots variations in open/tacit versus closed/codified system architectures supporting or limiting innovation capacity and new-business creation in targeted sectors. Aggregate global- and microlevel data are analyzed to identify concentrations of innovation and firm-level activity. Emerging hubs of knowledge and firm creation in biomedical industries, including biopharmaceuticals, are identified. Aggregate data is supplemented with firm-level case studies and interviews with entrepreneurs, government officials, incubation managers, and investors. The conceptual framework outlined in Chapter 1 and specified in Chapter 2 provides the lens through which innovation and entrepreneurship strategies in China, India, Japan, and Singapore are viewed. The analysis is supplemented with firm-level entrepreneurial case studies.